A30
Conditions
Interventions
Group 1: Patients with a first diagnosis of leprosy in Germany whose anonymized clinical and epidemiological data are retrospectively collected and analyzed.
Sponsors
Universitätsklinikum Hamburg-Eppendorf
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: First diagnosis of leprosy in Germany Diagnosis made between 01 January 2010 and 31 December 2024 Diagnosis and/or treatment at one of the participating study centers Availability of anonymized epidemiological and clinical baseline data
Exclusion criteria
Exclusion criteria: Leprosy diagnoses outside the defined study period Patients diagnosed with leprosy before entering Germany without a first diagnosis in Germany Cases with insufficient or non-analyzable data Non-anonymized datasets
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification and characterization of all leprosy first diagnoses in Germany between 2010 and 2024, including epidemiological and clinical characteristics. | — |
Secondary
| Measure | Time frame |
|---|---|
| Description of demographic characteristics of patients Characterization of clinical manifestations and disease types Analysis of diagnostic approaches Description of treatment, disease course, and follow-up Temporal and regional distribution of leprosy diagnoses in Germany | — |
Countries
Germany
Contacts
Public ContactThomas Theo Brehm
Universitätsklinikum Hamburg-Eppendorf
Outcome results
None listed